Natalie Mariam Salas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Natalie Mariam Salas has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Anne Acnp-Bc Kalunian
From the Division of Infectious Disease, Department of Internal Medicine, University of New Mexico Hospital Health Science Center, Albuquerque, NM
1 shared publication- Badr A. Badr
University of New Mexico Health Sciences Center School of Medicine
1 shared publication - Bernadette Jakeman
Department of Pharmacy Practice and Administrative Sciences, University of New Mexico College of Pharmacy, Albuquerque, NM, USA
1 shared publication Chelsea Rodriguez
Department of Pharmacy, University of New Mexico Hospitals, Albuquerque, NM, USA
1 shared publicationLucy Ruan
Department of Internal Medicine, Division of Infectious Diseases, University of New Mexico Hospitals, Albuquerque, NM, USA
1 shared publication- Madelin J. Whelpley
University of New Mexico Health Science Center School of Medicine
1 shared publication
Latest Publications
- 1 June 2026
- Published by Journal of Graduate Medical Education in Journal of Graduate Medical Education
- Vol. 18 (3) , 351-357
Using Authentic Patient Narratives to Introduce Social Determinants of Health in Graduate Medical Education Orientation
Background: Residency orientation provides a unique opportunity to introduce an interdisciplinary group of resident physicians to locally relevant social determinants of health (SDOH). Objective: To compare residents’ ability to address SDOH before and after an orientation workshop and describe the feasibility and acceptance of utilizing authentic patient narratives in teaching SDOH. Methods: All incoming residents at the University of New Mexico in 2 consecutive academic years (AY 2023-2024 and 2024-2025) participated in the workshop. Large group lectures complemented small-group case-based exercises on recognizing and addressing SDOH. In the second year, video excerpts of real patients narrating their experiences with health care were incorporated. A post-session survey measured self-reported ability to recognize and address SDOH. Results: One hundred seven of 164 (65%) residents in AY 2023-2024 and 91 of 173 (53%) residents in AY 2024-2025 completed the survey. Both sessions demonstrated statistically significant ( P <.001) improvement in resident self-reported ability to: (1) recognize SDOH (pre- and post-workshop mean scores 8.32 [SD 1.17] vs 6.83 [SD 1.89] in AY 2023-2024; 8.67 [SD 1.06] vs 6.97 [SD 2.06] in AY 2024-2025), and (2) address SDOH (7.98 [SD 1.37] vs 6.32 [SD 1.96]; 8.48 [SD 1.28] vs 6.99 [SD 2.00]). Patient videos supported learning, demonstrated by an increase in effect size (Cohen’s d 0.1 vs 1.04). Twelve to 18 hours were needed to develop workshop materials, with an additional 6.5 hours required for administrative and facilitator time. Conclusions: A workshop during graduate medical education orientation introducing SDOH using authentic patient narratives increased residents’ self-reported ability to address SDOH specific to their new patient populations.
- 1 June 2026
- Published by Journal of Graduate Medical Education in Journal of Graduate Medical Education
- Vol. 18 (3) , 351-357
Using Authentic Patient Narratives to Introduce Social Determinants of Health in Graduate Medical Education Orientation
Background: Residency orientation provides a unique opportunity to introduce an interdisciplinary group of resident physicians to locally relevant social determinants of health (SDOH). Objective: To compare residents’ ability to address SDOH before and after an orientation workshop and describe the feasibility and acceptance of utilizing authentic patient narratives in teaching SDOH. Methods: All incoming residents at the University of New Mexico in 2 consecutive academic years (AY 2023-2024 and 2024-2025) participated in the workshop. Large group lectures complemented small-group case-based exercises on recognizing and addressing SDOH. In the second year, video excerpts of real patients narrating their experiences with health care were incorporated. A post-session survey measured self-reported ability to recognize and address SDOH. Results: One hundred seven of 164 (65%) residents in AY 2023-2024 and 91 of 173 (53%) residents in AY 2024-2025 completed the survey. Both sessions demonstrated statistically significant ( P <.001) improvement in resident self-reported ability to: (1) recognize SDOH (pre- and post-workshop mean scores 8.32 [SD 1.17] vs 6.83 [SD 1.89] in AY 2023-2024; 8.67 [SD 1.06] vs 6.97 [SD 2.06] in AY 2024-2025), and (2) address SDOH (7.98 [SD 1.37] vs 6.32 [SD 1.96]; 8.48 [SD 1.28] vs 6.99 [SD 2.00]). Patient videos supported learning, demonstrated by an increase in effect size (Cohen’s d 0.1 vs 1.04). Twelve to 18 hours were needed to develop workshop materials, with an additional 6.5 hours required for administrative and facilitator time. Conclusions: A workshop during graduate medical education orientation introducing SDOH using authentic patient narratives increased residents’ self-reported ability to address SDOH specific to their new patient populations.
- 18 December 2025
- Published by Springer Nature
- p. 1-27
Bunyaviruses: Hantaviruses
- 11 January 2023
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 34 (5) , 355-360
Treatment management of M. simiae infection complicated by severe immune reconstitution syndrome in two patients living with HIV
Nontuberculosis mycobacterium are increasingly being identified as sources of disseminated infections in immunocompromised patients. These infections can be challenging to identify and treat due complexities of diagnosis and inherent resistance to many medications. We present two cases of patients with human immunodeficiency virus who had Mycobacterium simiae infections, complicated by immune reconstruction inflammatory syndrome (IRIS). We also present a review of the English literature surrounding the disease, including reported resistance patterns to antimicrobial therapy, which can be highly variable.
- 11 January 2023
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 34 (5) , 355-360
Treatment management of M. simiae infection complicated by severe immune reconstitution syndrome in two patients living with HIV
Nontuberculosis mycobacterium are increasingly being identified as sources of disseminated infections in immunocompromised patients. These infections can be challenging to identify and treat due complexities of diagnosis and inherent resistance to many medications. We present two cases of patients with human immunodeficiency virus who had Mycobacterium simiae infections, complicated by immune reconstruction inflammatory syndrome (IRIS). We also present a review of the English literature surrounding the disease, including reported resistance patterns to antimicrobial therapy, which can be highly variable.
- 1 July 2020
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 31 (9) , 911-913
Granulomatous interstitial nephritis in the setting of disseminated Mycobacterium simiae: a rare presentation of immune reconstitution inflammatory syndrome
Disseminated Mycobacterium simiae is a rare opportunistic infection reported most commonly in advanced human immunodeficiency virus (HIV) infection. Treatment can be further complicated by the occurrence of severe immune reconstitution inflammatory syndrome (IRIS). We present the first case of disseminated multi-drug-resistant M. simiae in the setting of advanced HIV, complicated by IRIS in the form of granulomatous interstitial nephritis causing acute renal failure. This case highlights the importance of recognizing rare complications of IRIS, as delays in therapy can be life threatening.
- 1 July 2020
- Published by SAGE Publications in International Journal of STD & AIDS
- Vol. 31 (9) , 911-913
Granulomatous interstitial nephritis in the setting of disseminated Mycobacterium simiae: a rare presentation of immune reconstitution inflammatory syndrome
Disseminated Mycobacterium simiae is a rare opportunistic infection reported most commonly in advanced human immunodeficiency virus (HIV) infection. Treatment can be further complicated by the occurrence of severe immune reconstitution inflammatory syndrome (IRIS). We present the first case of disseminated multi-drug-resistant M. simiae in the setting of advanced HIV, complicated by IRIS in the form of granulomatous interstitial nephritis causing acute renal failure. This case highlights the importance of recognizing rare complications of IRIS, as delays in therapy can be life threatening.
- 19 May 2020
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 28 (5) , 305-307
Silent but Deadly
Legionella species are a rare cause of culture-negative endocarditis. We report the first case of bioprosthetic valve endocarditis due to Legionella maceachernii. This case highlights the importance of the use of DNA target sequencing to identify the cause of culture-negative endocarditis, as standard empiric therapy would not have covered the identified organism.
- 19 May 2020
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 28 (5) , 305-307
Silent but Deadly
Legionella species are a rare cause of culture-negative endocarditis. We report the first case of bioprosthetic valve endocarditis due to Legionella maceachernii. This case highlights the importance of the use of DNA target sequencing to identify the cause of culture-negative endocarditis, as standard empiric therapy would not have covered the identified organism.
- Open Access
- 1 March 2017
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 25 (2) , 62-65
Mycobacterium goodii: An Emerging Nosocomial Pathogen
Mycobacterium goodii, a rapidly growing nontuberculous mycobacterium, is an emerging pathogen in nosocomial infections. Its inherent resistance patterns make it a challenging organism to treat, and delays in identification can lead to poor outcomes. We present a case of cardiac device pocket infection with M. goodii, complicated by both antibiotic resistance and drug reactions that highlight the challenges faced by clinicians trying to eradicate these infections. We also present a brief review of the English literature surrounding this disease, including a table of all reported cases of M. goodii infections and their outcomes to act as guide for clinicians formulating treatment plans for these infections. A clear understanding of diagnostic methods and treatment caveats is essential to curing infections caused by these organisms.
- 1 March 2017
- Published by Wolters Kluwer Health in Infectious Diseases in Clinical Practice
- Vol. 25 (2) , 62-65
Open AccessMycobacterium goodii: An Emerging Nosocomial Pathogen
Mycobacterium goodii, a rapidly growing nontuberculous mycobacterium, is an emerging pathogen in nosocomial infections. Its inherent resistance patterns make it a challenging organism to treat, and delays in identification can lead to poor outcomes. We present a case of cardiac device pocket infection with M. goodii, complicated by both antibiotic resistance and drug reactions that highlight the challenges faced by clinicians trying to eradicate these infections. We also present a brief review of the English literature surrounding this disease, including a table of all reported cases of M. goodii infections and their outcomes to act as guide for clinicians formulating treatment plans for these infections. A clear understanding of diagnostic methods and treatment caveats is essential to curing infections caused by these organisms.